Early and accelerated access programs for medical devices in the European Union: mapping regulatory derogations and national schemes
{{output}}
Background: Early access programs (EAPs) can provide patients with medical devices before full market access in urgent or high unmet-need situations. Unlike pharmaceuticals, the European Union (EU) has no harmonised early-access ... ...
